Form 4: BioAtla Director Lawrence Steinman Receives 23,500 Restricted Stock Units

BioAtla, Inc. Director Lawrence Steinman was granted 23,500 shares of common stock in the form of a time-based restricted stock unit award on June 18, 2025, increasing his beneficial ownership to 78,459 shares.

Summary

• Lawrence Steinman, a Director of BioAtla, Inc. (BCAB), reported an acquisition of company stock.
• The transaction occurred on June 18, 2025.
• Mr. Steinman acquired 23,500 shares of Common Stock.
• This acquisition represents a time-based Restricted Stock Unit (RSU) award, with a reported price of $0 per share.
• The RSU award is set to vest 100% on the earlier of June 18, 2026, or the date of the next Company annual meeting of stockholders, contingent upon Mr. Steinman's continued service.
• Following this transaction, Lawrence Steinman beneficially owns a total of 78,459 shares of BioAtla, Inc. Common Stock.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a director is a positive sign of alignment between management and shareholder interests, as it ties compensation to future company performance and continued service. However, it is a routine compensation event rather than a significant operational or financial announcement.

Positives

• The grant of 23,500 Restricted Stock Units (RSUs) to Director Lawrence Steinman aligns his interests with long-term shareholder value, as the award vests based on continued service.
• The increase in Director Lawrence Steinman's beneficial ownership to 78,459 shares demonstrates continued commitment to BioAtla, Inc.

Future Outlook

The 23,500 Restricted Stock Units granted to Director Lawrence Steinman are scheduled to vest 100% on the earlier of June 18, 2026, or the next Company annual meeting of stockholders, subject to his continued service.

Industry Context

This Form 4 filing details an individual insider transaction, which is a routine disclosure for publicly traded companies. It does not provide information on broader industry trends or competitive landscape.

Related Party Transactions

• The grant of 23,500 Restricted Stock Units to Director Lawrence Steinman represents a compensation arrangement between the company and a related party (director).

Stakeholder Impact

• Shareholders: The equity grant aligns the director's interests with long-term shareholder value, as the vesting is contingent on continued service and future performance.

Next Steps

• Vesting of the 23,500 Restricted Stock Units on the earlier of June 18, 2026, or the next Company annual meeting of stockholders.

Key Dates

Keywords

BioAtla, BCAB, Form 4, SEC filing, insider transaction, restricted stock unit, RSU, director compensation, equity grant